FFVAX | FSNLX | FFVAX / FSNLX | |
Total Expense Ratio | 0.75 | 0.45 | 167% |
Annual Report Gross Expense Ratio | 0.75 | 0.45 | 167% |
Fund Existence | 22 years | 8 years | - |
Gain YTD | 4.228 | 5.123 | 83% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 436M | 4.38B | 10% |
Annual Yield % from dividends | 2.41 | 2.74 | 88% |
Returns for 1 year | 3.72 | 5.03 | 74% |
Returns for 3 years | 19.08 | 21.70 | 88% |
Returns for 5 years | 2.91 | 6.11 | 48% |
Returns for 10 years | -0.99 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AICFX | 63.83 | 0.22 | +0.35% |
American Funds Invmt Co of Amer F1 | |||
SGDIX | 76.66 | N/A | N/A |
Sprott Gold Equity Institutional | |||
EKGAX | 36.84 | N/A | N/A |
Allspring Special Global Small Cap A | |||
EMPTX | 8.99 | N/A | N/A |
UBS Emerging Markets Equity Opp P2 | |||
GQEIX | 21.72 | N/A | N/A |
GQG Partners US Select Quality Eq Instl |